首页> 外文OA文献 >High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed/refractory lymphoma: An effective regimen with low morbidity and mortality

【2h】

High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed/refractory lymphoma: An effective regimen with low morbidity and mortality

机译：大剂量卡莫司汀，依托泊苷和顺铂用于自体干细胞移植（伴有或不伴有场辐射）用于复发/难治性淋巴瘤：一种有效的方案，发病率和死亡率低

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Wadhwa Punit D.; Fu Pingfu; Koc Omer N.; Cooper Brenda W.; Fox Robert M.; Creger Richard J.; Bajor David L.; Bedi Teja; Laughlin Mary J.; Payne Jennifer; Gerson Stanton L.; Lazarus Hillard M.;
展开▼
作者单位

展开▼
年度 2005
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
专利

1. 小剂量周方案单药司莫司汀治疗伴有广泛皮下转移的MGMT甲基化阳性的非特异性外周T细胞淋巴瘤1例报道 [J] . Wei Ren, Baorui Liu, Li Xie, 中德临床肿瘤学杂志（英文版） . 2012 ,第009期
2. High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed/refractory lymphoma: An effective regimen with low morbidity and mortality. [J] . Wadhwa PD, Fu P, Koc ON, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2005 ,第1期

机译：大剂量卡莫司汀，依托泊苷和顺铂用于自体干细胞移植（伴有或不伴有受累野放射线）用于复发/难治性淋巴瘤：一种有效的方案，发病率和死亡率低。
3. Regimen-related toxicity and non-relapse mortality with high-dose cyclophosphamide, carmustine (BCNU) and etoposide (VP16-213) (CBV) and CBV plus cisplatin (CBVP) followed by autologous stem cell transplantation in patients with Hodgkin's disease. [J] . Reece DE, Nevill TJ, Sayegh A, Bone marrow transplantation . 1999 ,第11期

机译：在霍奇金病患者中，大剂量环磷酰胺，卡莫司汀（BCNU）和依托泊苷（VP16-213）（CBV）和CBV加顺铂（CBVP）进行与方案相关的毒性和非复发死亡率，然后进行自体干细胞移植。
4. Augmented high-dose regimen of cyclophosphamide, carmustine, and etoposide with autologous hematopoietic stem cell transplantation for relapsed and refractory aggressive non-Hodgkin's lymphoma. [J] . Robertson MJ, Abonour R, Hromas R, Leukemia and lymphoma . 2005 ,第10期

机译：增强的大剂量环磷酰胺，卡莫司汀和依托泊苷联合自体造血干细胞移植治疗复发性和难治性侵袭性非霍奇金淋巴瘤。
5. Clinical Outcome of Breast and Ovarian Cancer Patients Treated after High-Dose Chemotherapy and Autologous Stem Cell Rescue with Theratope (STn-KLH) Cancer Vaccine: Theratope (STn-KLH) Cancer Vaccine following Autologous Transplant [C] . Leona A. Holmberg, Katherine A. Guthrie, Brenda M. Sandmaier Chemical glycobiology . -1

机译：大剂量化学疗法和自体干细胞拯救治疗的Theratope（STn-KLH）癌症疫苗治疗的乳腺癌和卵巢癌患者的临床结果：自体移植后的Theratope（STn-KLH）癌症疫苗
6. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
7. A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma [O] . Auayporn Nademanee, Stephen Forman, Arturo Molina, -1

机译：高危钇或复发性非霍奇金淋巴瘤患者的高剂量钇90-阿比特单抗tiuxetan联合高剂量依托泊苷和环磷酰胺联合自体干细胞移植的1/2期临床试验
8. Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma [O] . M Benekli, S L Smiley, T Younis, 2007

机译：依托泊苷（VP-16），环磷酰胺和甘蔗（VCB）的强化调理方案，然后是自体造血干细胞移植进行复发和难治性Hodgkin的淋巴瘤

High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed/refractory lymphoma: An effective regimen with low morbidity and mortality

著录项

相似文献

相关主题

期刊订阅